Tissue reactions to engineered cartilage based on poly-l-lactic acid scaffolds

Tissue Engineering - Part A

Volumn 15, Issue 7, 2009, Pages 1565-1577

  Fujihara, Yuko ^a   Asawa, Yukiyo ^a   Takato, Tsuyoshi ^a   Hoshi, Kazuto ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMERS; BLOOD; CARTILAGE; LACTIC ACID; LIGAMENTS; MACROPHAGES; ORGANIC ACIDS; ORGANIC POLYMERS; SCAFFOLDS;

ATELOCOLLAGEN; CARTILAGE REGENERATION; CHONDROCYTES; ENGINEERED CARTILAGE; ENGINEERED TISSUES; HUMAN CHONDROCYTES; INTERLEUKIN-1; MACROPHAGE ACTIVATION; MIGRATION INHIBITORY FACTORS; NEOVASCULARIZATION; NUDE MICE; PLLA; POLY L LACTIC ACID; TISSUE REACTIONS;

BLOOD VESSELS;

ATELOCOLLAGEN; BIOPOLYMER; HEMOGLOBIN; INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; POLYLACTIC ACID; SCAFFOLD PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CARTILAGE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE TRANSPLANTATION;

MUS MUSCULUS;

EID: 67650682084     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0154     Document Type: Article

References (36)

1. Gopferich, A. Mechanisms of polymer degradation and erosion. Biomaterials 17, 103, 1996.
2. Nakamura, S., Ninomiya, S., Takatori, Y., Morimoto, S., Kusaba, I., and Kurokawa, T. Polylactide screws in acetabular osteotomy. 28 dysplastic hips followed for 1 year. Acta Orthop Scand 64, 301, 1993.
3. Kulkarni, R.K., Pani, K.C., Neuman, C., and Leonard, F. Polylactic acid for surgical implants. Arch Surg 93, 839, 1966.
4. Morgan, C.D., Gehrmann, R.M., Jayo, M.J., and Johnson, C.S. Histologic findings with a bioabsorbable anterior cruciate ligament interference screw explant after 2.5 years in vivo. Arthroscopy. 18, E47, 2002.
5. Freed, L.E., Marquis, J.C., Nohria, A., Emmanual, J., Mikos, A.G., and Langer, R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27, 11, 1993.
6. Ishaug, S.L., Crane, G.M., Miller, M.J., Yasko, A.W., Yaszemski, M.J., and Mikos, A.G. Bone formation by threedimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 36, 17, 1997.
7. Zacchi, V., Soranzo, C., Cortivo, R., Radice, M., Brun, P., and Abatangelo, G. In vitro engineering of human skin-like tissue. J Biomed Mater Res 40, 187, 1998.
8. Lin, V.S., Lee, M.C., O'Neal, S., McKean, J., and Sung, K.L. Ligament tissue engineering using synthetic biodegradable fiber scaffolds. Tissue Eng 5, 443, 1999.
9. Oberpenning, F., Meng, J., Yoo, J.J., and Atala, A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17, 149, 1999.
10. Cusick, R.A., Lee, H., Sano, K., Pollok, J.M., Utsunomiya, H., Ma, P.X., Langer, R., and Vacanti, J.P. The effect of donor and recipient age on engraftment of tissue-engineered liver. J Pediatr Surg 32, 357, 1997.
11. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
12. Ochi, M., Adachi, N., Nobuto, H., Yanada, S., Ito, Y., and Agung, M. Articular cartilage repair using tissue engineering technique-novel approach with minimally invasive procedure. Artif Organs 28, 28, 2004.
13. Yanaga, H., Yanaga, K., Imai, K., Koga, M., Soejima, C., and Ohmori, K. Clinical application of cultured autologous human auricular chondrocytes with autologous serum for craniofacial or nasal augmentation and repair. Plast Reconstr Surg 117, 2019, 2006.
14. Walton, M. and Cotton, N.J. Long-term in vivo degradation of poly-L-lactide (PLLA) in bone. J Biomater Appl 21, 395, 2007.
15. Gogolewski, S., Jovanovic, M., Perren, S.M., Dillon, J.G., and Hughes, M.K. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrateco-3-hydroxyvalerate) (PHB=VA). J Biomed Mater Res 27,1135, 1993.
16. Yamaoka, H., Asato, H., Ogasawara, T., Nishizawa, S., Takahashi, T., Nakatsuka, T., Koshima, I., Nakamura, K., Kawaguchi, H., Chung, U.I., Takato, T., and Hoshi, K. Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials. J Biomed Mater Res A 78, 1, 2006.
17. Hoshi, K., Amizuka, N., Sakou, T., Kurokawa, T., and Ozawa, H. Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2: morphological examinations for ossification of spinal ligaments. Bone 21, 155, 1997.
18. Ohara, N., Koyama, H., Miyata, T., Hamada, H., Miyatake, S.I., Akimoto, M., and Shigematsu, H. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther 8, 837, 2001.
19. Fujihara, Y., Koyama, H., Ohba, M., Tabata, Y., Fujihara, H., Yonehara, Y., and Takato, T. Controlled delivery of bFGF to recipient bed enhances the vascularization and viability of an ischemic skin flap. Wound Repair Regen 16, 125, 2008.
20. Kampfer, H., Kolb, N., Manderscheid, M., Wetzler, C., Pfeilschifter, J., and Frank, S. Macrophage-derived hemeoxygenase-1: expression, regulation, and possible functions in skin repair. Mol Med 7, 488, 2001.
21. Kamei, D., Yamakawa, K., Takegoshi, Y., Mikami-Nakanishi, M., Nakatani, Y., Oh-Ishi, S., Yasui, H., Azuma, Y., Hirasawa, N., Ohuchi, K., Kawaguchi, H., Ishikawa, Y., Ishii, T., Uematsu, S., Akira, S., Murakami, M., and Kudo, I. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J Biol Chem 279, 33684, 2004.
22. Liu, G., Kawaguchi, H., Ogasawara, T., Asawa, Y., Kishimoto, J., Takahashi, T., Chung, U.I., Yamaoka, H., Asato, H., Nakamura, K., Takato, T., and Hoshi, K. Optimal combination of soluble factors for tissue engineering of permanent cartilage from cultured human chondrocytes. J Biol Chem 282, 20407, 2007.
23. Beekman, B., Verzijl, N., de Roos, J.A., and TeKoppele, J.M. Matrix degradation by chondrocytes cultured in alginate: IL-1 beta induces proteoglycan degradation and proMMP synthesis but does not result in collagen degradation. Osteoarthritis Cartilage 6, 330, 1998.
24. Loeser, R.F. Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum 54, 1357, 2006.
25. Pontz, B., Meigel, W., Rauterberg, J., and Kuhn, K. Localization of two species specific antigenic determinants on the peptide chains of calf skin collagen. Eur J Biochem16, 50, 1970.
26. Davison, P.F., Levine, L., Drake, M.P., Rubin, A., and Bump, S. The serologic specificity of tropocollagen telopeptides. J Exp Med 126, 331, 1967.
27. Barker, C.F. and Billingham, R.E. Immunologically privileged sites. Adv Immunol 25, 1, 1977.
28. Cobbold, S.P., Adams, E., Graca, L., Daley, S., Yates, S., Paterson, A., Robertson, N.J., Nolan, K.F., Fairchild, P.J., and Waldmann,H. Immune privilege induced by regulatoryT cells in transplantation tolerance. Immunol Rev 213, 239, 2006.
29. Streilein, J.W. and Stein-Streilein, J. Does innate immune privilege exist? J Leukoc Biol 67, 479, 2000.
30. Taylor, A.W., Streilein, J.W., and Cousins, S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11, 1199, 1992.
31. Apte, R.S., Sinha, D., Mayhew, E., Wistow, G.J., and Niederkorn, J.Y. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160, 5693, 1998.
32. Lind, M., Trindade, M.C., Nakashima, Y., Schurman, D.J., Goodman, S.B., and Smith, L. Chemotaxis and activation of particle-challenged human monocytes in response to monocyte migration inhibitory factor and C-C chemokines. J Biomed Mater Res 48, 246, 1999.
33. Baugh, J.A., Chitnis, S., Donnelly, S.C., Monteiro, J., Lin, X., Plant, B.J., Wolfe, F., Gregersen, P.K., and Bucala, R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF ) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3, 170, 2002.
34. Burger-Kentischer, A., Goebel, H., Seiler, R., Fraedrich, G., Schaefer, H.E., Dimmeler, S., Kleemann, R., Bernhagen, J., and Ihling, C. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105, 1561, 2002.
35. Bernhagen, J., Calandra, T., Mitchell, R.A., Martin, S.B., Tracey, K.J., Voelter, W., Manogue, K.R., Cerami, A., and Bucala, R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756, 1993.
36. Mizue, Y., Ghani, S., Leng, L., McDonald, C., Kong, P., Baugh, J., Lane, S.J., Craft, J., Nishihira, J., Donnelly, S.C., Zhu, Z., and Bucala, R. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A 102,14410, 2005.